Major Depressive Disorder
Showing NaN - NaN of 75
MDD Trial in United States (SAGE-217, Placebo)
Migraine, MDD Trial in Worldwide (Fremanezumab, Placebo)
Completed
- Migraine
- Major Depressive Disorder
- Fremanezumab
- Placebo
-
Little Rock, Arkansas
- +63 more
Dec 7, 2022
MDD, Treatment Resistant Depression, Depression Trial in United States (AXS-05)
Completed
- Major Depressive Disorder
- +2 more
- AXS-05 (dextromethorphan and bupropion) oral tablets
-
Phoenix, Arizona
- +50 more
Sep 16, 2022
MDD Trial in Australia, United States (10 mg PRAX-114, 20 mg PRAX-114, 40 mg PRAX-114)
Completed
- Major Depressive Disorder
- 10 mg PRAX-114
- +4 more
-
Lafayette, California
- +23 more
Aug 18, 2022
MDD Trial in United States (SP-624, Placebo)
Active, not recruiting
- Major Depressive Disorder
- SP-624
- Placebo
-
Phoenix, Arizona
- +38 more
May 13, 2022
MDD Trial in United States (BTRX-335140, Placebo)
Active, not recruiting
- Major Depressive Disorder
- BTRX-335140
- Placebo
-
Phoenix, Arizona
- +37 more
Mar 11, 2022
Depression, MDD Trial in United States (AXS-05, Placebo)
Completed
- Depression
- Major Depressive Disorder
- AXS-05
- Placebo
-
Phoenix, Arizona
- +42 more
Sep 22, 2021
MDD Trial in Worldwide (SPD489 (Lisdexamfetamine dimesylate) + Antidepressant)
Terminated
- Major Depressive Disorder
- SPD489 (Lisdexamfetamine dimesylate) + Antidepressant
-
Birmingham, Alabama
- +211 more
Jun 9, 2021
MDD Trial in United States (BTRX-246040 oral capsule(s), Placebo oral capsule(s))
Completed
- Major Depressive Disorder
- BTRX-246040 oral capsule(s)
- Placebo oral capsule(s)
-
Cerritos, California
- +7 more
Apr 19, 2021
MDD Trial in Australia, Puerto Rico, United States (ALKS 5461, ALKS 5461 Placebo)
Completed
- Major Depressive Disorder
- ALKS 5461
- ALKS 5461 Placebo
-
Tucson, Arizona
- +34 more
Mar 15, 2021
MDD Trial in United States (Vortioxetine, Placebo)
MDD Trial in Puerto Rico, United States (Agomelatine (AGO178C), Placebo)
Completed
- Major Depressive Disorder
- Agomelatine (AGO178C)
- Placebo
-
Birmingham, Alabama
- +44 more
Dec 16, 2020
MDD Trial in United States (Assay-guided treatment (AGT), Treatment-as-usual (TAU))
Completed
- Major Depressive Disorder
- Assay-guided treatment (AGT)
- Treatment-as-usual (TAU)
-
Birmingham, Alabama
- +22 more
Aug 27, 2020
Depression, MDD Trial in Canada, United States (Levomilnacipran ER, Placebo)
Completed
- Depression
- Major Depressive Disorder
- Levomilnacipran ER
- Placebo
-
Beverly Hills, California
- +34 more
Dec 23, 2019
MDD Trial in United States (Placebo, Vilazodone)
MDD Trial in Canada, United States (Vilazodone)
Completed
- Major Depressive Disorder
-
Birmingham, Alabama
- +55 more
Sep 10, 2019
MDD Trial in Worldwide (ALKS 5461, Placebo)
Completed
- Major Depressive Disorder
- ALKS 5461
- Placebo
-
Birmingham, Alabama
- +43 more
Aug 2, 2019
MDD Trial in Bulgaria, United States (ALKS 5461, Placebo)
Completed
- Major Depressive Disorder
- ALKS 5461
- Placebo
-
Little Rock, Arkansas
- +57 more
May 31, 2019